SIRT6 and hepatocellular carcinoma: They also showed that MDL-800 can arrest the cell cycle of human hepatocellular carcinoma (HCC) cells and inhibit HCC in a xenograft mice model by enhancing the activity of SIRT6 deacetylation [76].